In Teva Branded Pharm. Prods. R&D v. Amneal Pharms. of N.Y., LLC, the US District Court for the District of New Jersey ordered Teva to delist five patents from the Food and Drug Administration (FDA)’s ...
The Federal Trade Commission (“FTC”) has filed an amicus brief in Teva Branded Pharmaceuticals Products R&D, Inc. v. Amneal Pharmaceuticals of New York, LLC to further the agency’s efforts to promote ...
When it comes to questioning drug patents, the U.S. Federal Trade Commission (FTC) isn’t backing down. After filing a challenge in November against more than 100 patents in the FDA’s Orange Book—and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback